[1] |
王静, 郑群, 金霞霞, 等. RDW与NLR联合检测在强直性脊柱炎中的临床意义[J]. 检验医学, 2019, 34(8):704-709.
|
[2] |
CHEN L, AL-MOSSAWI M H, RIDLEY A, et al. MiR-10b-5p is a novel Th17 regulator present in Th17 cells from ankylosing spondylitis[J]. Ann Rheum Dis, 2017, 76(3):620-625.
DOI
URL
|
[3] |
GUO N, ZHANG K, GAO X, et al. Role and mechanism of LAIR-1 in the development of autoimmune diseases,tumors,and malaria:a review[J]. Curr Res Transl Med, 2020, 68(3):119-124.
DOI
URL
|
[4] |
BRAUN J, VAN DEN BERG R, BARALIAKOS X, et al. 2010 Update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis[J]. Ann Rheum Dis,2011, 70(6):896-904.
DOI
URL
|
[5] |
MACHADO P M, LANDEWÉ R, HEIJDE D V, et al. Ankylosing spondylitis disease activity score(ASDAS):2018 update of the nomenclature for disease activity states[J]. Ann Rheum Dis, 2018, 77(10):1539-1540.
DOI
URL
|
[6] |
SCHNEEBERGER E E, ZAMORA N, CITERA G. SASDAS(simplified version of ankylosing spondylitis disease activity score)-ESR performance and development of SASDAS-CRP and their agreement with ASDAS-ESR and ASDAS-CRP in patients with ankylosing spondylitis[J]. Clin Rheumatol, 2016, 35(11):2865-2866.
DOI
URL
|
[7] |
JIN J, WANG Y, MA Q, et al. LAIR-1 activation inhibits inflammatory macrophage phenotype in vitro[J]. Cell Immunol, 2018, 331:78-84.
DOI
URL
|
[8] |
JANSEN C A, CRUIJSEN C W, DE RUITER T, et al. Regulated expression of the inhibitory receptor LAIR-1 on human peripheral T cells during T cell activation and differentiation[J]. Eur J Immunol, 2007, 37(4):914-924.
PMID
|
[9] |
SON M, DIAMOND B. C1q-mediated repression of human monocytes is regulated by leukocyte-associated Ig-like receptor 1(LAIR-1)[J]. Mol Med, 2015, 20(1):559-568.
DOI
URL
|
[10] |
MERLO A, TENCA C, FAIS F, et al. Inhibitory receptors CD85j,LAIR-1,and CD152 down-regulate immunoglobulin and cytokine production by human B lymphocytes[J]. Clin Diagn Lab Immunol, 2005, 12(6):705-712.
|
[11] |
SON M, SANTIAGO-SCHWARZ F, AL-ABED Y, et al. C1q limits dendritic cell differentiation and activation by engaging LAIR-1[J]. Proc Natl Acad Sci U S A, 2012, 109(46):E3160-E3167.
|
[12] |
BONACCORSI I, CANTONI C, CARREGA P, et al. The immune inhibitory receptor LAIR-1 is highly expressed by plasmacytoid dendritic cells and acts complementary with NKp44 to control IFNα production[J]. PLoS One, 2010, 5(11):e15080.
|
[13] |
OLDE NORDKAMP M J, VAN ROON J A, DOUWES M, et al. Enhanced secretion of leukocyte-associated immunoglobulin-like receptor 2(LAIR-2) and soluble LAIR-1 in rheumatoid arthritis:LAIR-2 is a more efficient antagonist of the LAIR-1-collagen inhibitory interaction than is soluble LAIR-1[J]. Arthritis Rheum, 2011, 63(12):3749-3757.
DOI
URL
|
[14] |
ZHANG Y, WANG S, DONG H, et al. LAIR-1 shedding from human fibroblast-like synoviocytes in rheumatoid arthritis following TNF-α stimulation[J]. Clin Exp Immunol, 2018, 192(2):193-205.
DOI
URL
|
[15] |
KIM S, EASTERLING E R, PRICE L C, et al. The role of leukocyte-associated Ig-like receptor-1 in suppressing collagen-induced arthritis[J]. J Immunol, 2017, 199(8):2692-2700.
DOI
URL
|
[16] |
OLDE NORDKAMP MJ, VAN ROON JA, DOUWES M, et al. Enhanced secretion of leukocyte-associated immunoglobulin-like receptor 2(LAIR-2) and soluble LAIR-1 in rheumatoid arthritis:LAIR-2 is a more efficient antagonist of the LAIR-1-collagen inhibitory interaction than is soluble LAIR-1[J]. Arthritis Rheum, 2011, 63(12):3749-3757.
DOI
URL
|
[17] |
GU Y, BI Y, WEI H, et al. Expression and clinical significance of inhibitory receptor leukocyte-associated immunoglobulin-like receptor-1 on peripheral blood T cells of chronic hepatitis B patients:a cross-sectional study[J]. Medicine(Baltimore), 2021, 100(29):e26667.
|
[18] |
黄美玲, 李长钢, 王国兵, 等. 白细胞相关免疫球蛋白样受体-1在免疫性血小板减少症患儿中的表达[J]. 中国当代儿科杂志, 2014, 16(4):370-374.
|